Dehao Tu

High epiregulin (<i>EREG</i>) gene expression plus <i>K-ras</i> wild-type (WT) status as predictors of cetuximab benefit in the treatment of advanced colorectal cancer (ACRC): Results from NCIC CTG CO.17—A phase III trial of cetuximab versus best supportive care (BSC)

Derek J. Jonker, Christos S. Karapetis, Christopher Harbison et al. · Journal of Clinical Oncology · 2009 · 39 citations

Immunology, Pathology, Advanced Colorectal Cancer +20

Electromagnetic Navigation Bronchoscopy-Guided Microwave Ablation Combined With Uniportal Video-Assisted Thoracoscopic Surgery for Multiple Ground Glass Opacities

Rirong Qu, Dehao Tu, Shaojie Hu et al. · The Annals of Thoracic Surgery · 2021 · 24 citations

Medical Imaging, Minimally Invasive Procedure, Thoracic Surgery +5

Radar‐based human identification using deep neural network for long‐term stability

Shiqi Dong, Weijie Xia, Yi Li et al. · IET Radar Sonar & Navigation · 2020 · 16 citations · Full text

Quality of life in patients with advanced colorectal cancer treated with cetuximab: Results of the NCIC CTG and AGITG CO.17 trial

H. Au, Christos S. Karapetis, Derek J. Jonker et al. · Journal of Clinical Oncology · 2007 · 14 citations

Agitg Co.17 Trial, Advanced Crc, Cetuximab Prolongs Survival +19

Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?

Rirong Qu, Dehao Tu, Ping Wei et al. · OncoTargets and Therapy · 2021 · 11 citations · Full text